Adagio Medical Holdings, Inc.
ADGM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | -$143 |
| % Growth | – | – | 100% | – |
| Cost of Goods Sold | $31 | $342 | $253 | $299 |
| Gross Profit | -$31 | -$342 | -$253 | -$442 |
| % Margin | – | – | – | 309.1% |
| R&D Expenses | $2,774 | $1,971 | $3,659 | $3,417 |
| G&A Expenses | $0 | $0 | $0 | $612 |
| SG&A Expenses | $2,916 | $0 | $0 | $2,793 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $2,181 |
| Other Operating Expenses | $0 | $2,404 | $3,485 | $44,659 |
| Operating Expenses | $5,690 | $4,375 | $7,144 | $50,368 |
| Operating Income | -$5,721 | -$4,717 | -$7,397 | -$50,784 |
| % Margin | – | – | – | 35,513.5% |
| Other Income/Exp. Net | -$4,397 | $770 | -$316 | $2,540 |
| Pre-Tax Income | -$10,118 | -$3,947 | -$7,713 | -$48,245 |
| Tax Expense | $0 | $0 | $0 | $9,124 |
| Net Income | -$10,118 | -$3,947 | -$7,713 | -$52,803 |
| % Margin | – | – | – | 36,925.4% |
| EPS | -0.66 | -0.26 | -0.5 | -3.55 |
| % Growth | -153.8% | 48% | 85.9% | – |
| EPS Diluted | -0.66 | -0.35 | -0.5 | -3.55 |
| Weighted Avg Shares Out | 15,382 | 15,382 | 15,376 | 14,867 |
| Weighted Avg Shares Out Dil | 15,382 | 15,382 | 15,376 | 14,867 |
| Supplemental Information | – | – | – | – |
| Interest Income | $79 | $102 | $164 | $753 |
| Interest Expense | $749 | $720 | $662 | $0 |
| Depreciation & Amortization | $191 | $271 | $271 | $424 |
| EBITDA | -$9,178 | -$4,446 | -$7,126 | -$56,275 |
| % Margin | – | – | – | 39,353.1% |